Copeland Capital Management LLC Has $78 Million Position in Chemed Co. (NYSE:CHE)

Copeland Capital Management LLC boosted its position in Chemed Co. (NYSE:CHE) by 1.0% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 129,789 shares of the company’s stock after buying an additional 1,297 shares during the period. Chemed comprises about 1.4% of Copeland Capital Management LLC’s portfolio, making the stock its 18th biggest holding. Copeland Capital Management LLC’s holdings in Chemed were worth $77,999,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CHE. GAMMA Investing LLC boosted its position in shares of Chemed by 34.4% in the second quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock valued at $47,000 after acquiring an additional 22 shares during the period. American National Bank & Trust acquired a new stake in Chemed in the 3rd quarter worth about $61,000. Mather Group LLC. bought a new stake in Chemed in the 1st quarter valued at about $67,000. EntryPoint Capital LLC increased its holdings in shares of Chemed by 14.0% during the first quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock worth $94,000 after purchasing an additional 18 shares during the period. Finally, Quarry LP increased its holdings in shares of Chemed by 721.7% during the second quarter. Quarry LP now owns 189 shares of the company’s stock worth $103,000 after purchasing an additional 166 shares during the period. 95.85% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, EVP Nicholas Michael Westfall sold 2,000 shares of the business’s stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $561.58, for a total transaction of $1,123,160.00. Following the completion of the transaction, the executive vice president now owns 5,990 shares of the company’s stock, valued at approximately $3,363,864.20. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, EVP Nicholas Michael Westfall sold 2,000 shares of Chemed stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $561.58, for a total transaction of $1,123,160.00. Following the sale, the executive vice president now directly owns 5,990 shares of the company’s stock, valued at approximately $3,363,864.20. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Andrea R. Lindell sold 831 shares of the stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $571.51, for a total transaction of $474,924.81. Following the completion of the transaction, the director now directly owns 5,725 shares of the company’s stock, valued at approximately $3,271,894.75. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 9,144 shares of company stock worth $5,264,839. Corporate insiders own 3.32% of the company’s stock.

Chemed Trading Down 1.6 %

NYSE CHE opened at $600.58 on Tuesday. The company has a market cap of $9.09 billion, a price-to-earnings ratio of 32.32, a PEG ratio of 2.44 and a beta of 0.44. Chemed Co. has a 1-year low of $502.64 and a 1-year high of $654.62. The company has a 50 day moving average of $584.35 and a 200-day moving average of $570.19.

Chemed (NYSE:CHE) last released its earnings results on Wednesday, July 24th. The company reported $5.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.59 by ($0.12). Chemed had a return on equity of 29.21% and a net margin of 12.88%. The company had revenue of $595.88 million for the quarter, compared to analyst estimates of $599.20 million. During the same period last year, the company posted $4.71 earnings per share. The business’s revenue for the quarter was up 7.6% compared to the same quarter last year. On average, equities research analysts forecast that Chemed Co. will post 21.77 earnings per share for the current year.

Chemed Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Monday, August 12th were given a $0.50 dividend. The ex-dividend date was Monday, August 12th. This is a boost from Chemed’s previous quarterly dividend of $0.40. This represents a $2.00 annualized dividend and a dividend yield of 0.33%. Chemed’s payout ratio is presently 10.76%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.